Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.

[1]  C. Shields,et al.  Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients. , 2002, Ophthalmology.

[2]  Y. Ohnishi,et al.  Neovascularization in the anterior segment of the rabbit eye by experimental anterior ischemia , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  L. Jampol,et al.  Preretinal neovascularisation associated with choroidal melanoma , 2001, The British journal of ophthalmology.

[4]  C. A. Aguilera,et al.  Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. , 2001, Ophthalmology.

[5]  I. McAllister,et al.  Iodine‐125 episcleral plaque therapy in uveal melanoma , 2000, Clinical & experimental ophthalmology.

[6]  P. Finger.  Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy , 2000, The British journal of ophthalmology.

[7]  C. Shields,et al.  Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. , 1999, Archives of ophthalmology.

[8]  D. Browning,et al.  The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. , 1998, Ophthalmology.

[9]  P. Finger.  Radiation therapy for choroidal melanoma. , 1997, Survey of ophthalmology.

[10]  J. Kongerud,et al.  Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma , 1997, The British journal of ophthalmology.

[11]  A. Tarkkanen,et al.  Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. , 1996, The British journal of ophthalmology.

[12]  J. Fontanesi,et al.  Treatment of choroidal melanoma with I-125 plaque. , 1993, International journal of radiation oncology, biology, physics.

[13]  P. Finger,et al.  Long-term results of iodine 125 irradiation of uveal melanoma. , 1992, Ophthalmology.

[14]  D. Browning.  Risk of missing angle neovascularization by omitting screening gonioscopy in patients with diabetes mellitus. , 1991, American journal of ophthalmology.

[15]  Z. Petrovich,et al.  An interactive treatment planning system for ophthalmic plaque radiotherapy. , 1990, International journal of radiation oncology, biology, physics.

[16]  J. Quivey,et al.  Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation. , 1989, Ophthalmology.

[17]  R. Glynn,et al.  The risk of enucleation after proton beam irradiation of uveal melanoma. , 1989, Ophthalmology.

[18]  A. Markoe,et al.  Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings. , 1989, Ophthalmology.

[19]  J. Sipperley,et al.  Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. , 1988, American journal of ophthalmology.

[20]  J. Shields,et al.  Panretinal photocoagulation for radiation-induced ocular ischemia. , 1987, Ophthalmic surgery.

[21]  G. Chen,et al.  Neovascular glaucoma after helium ion irradiation for uveal melanoma. , 1986, Ophthalmology.

[22]  D. Char,et al.  Complications of cobalt plaque therapy of choroidal malanomas. , 1977, American journal of ophthalmology.